Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Cord Blood Transplantation with Non-TBI-RIC Regimen Using Fludarabine and Melphalan for Adult T-Cell Leukemia / Lymphoma

Nobuaki Nakano, MD, Atae Utsunomiya, MD, Ayumu Kubota, MD, Masahito Tokunaga, MD PhD, Takayoshi Miyazono, MD PhD, Tomohisa Tabuchi, MD, Jun Odawara, MD PhD, Yoshikiyo Ito, MD PhD, Shogo Takeuchi, MD, Yoshifusa Takatsuka, MD

Blood (2019) 134 (Supplement_1): 1975.

https://doi.org/10.1182/blood-2019-126463

Published: 2019

Journal Articles

DS-3201, a Potent EZH1/2 Dual Inhibitor, Demonstrates Antitumor Activity Against Non-Hodgkin Lymphoma (NHL) Regardless of EZH2 Mutation

Blood (2018) 132 (Supplement 1): 2217.

https://doi.org/10.1182/blood-2018-99-113379

Published: 2018

Journal Articles

First-in-Human Study of the EZH1/2 Dual Inhibitor DS-3201b in Patients with Relapsed or Refractory Non-Hodgkin Lymphomas — Preliminary Results

Dai Maruyama, MD PhD, Kensei Tobinai, MD PhD, Shinichi Makita, MD, PhD, Takashi Ishida, MD PhD, Shigeru Kusumoto, MD, Kenji Ishitsuka, MD PhD, Makoto Yoshimitsu, MD PhD, Yoshitaka Imaizumi, MD PhD, Yasushi Sawayama, MD, PhD, Shogo Takeuchi, MD, Atae Utsunomiya, MD, PhD, Kunihiro Tsukasaki, MD PhD, Sumiaki Fujitani, MSc, Kazushi Araki, D.V.M., PhD

Blood (2017) 130 (Supplement 1): 4070.

https://doi.org/10.1182/blood.V130.Suppl_1.4070.4070

Published: 2017

Journal Articles

Population Pharmacokinetic and Exposure-Response Modeling for the EZH1/2 Dual Inhibitor DS-3201b in Patients with Non-Hodgkin Lymphomas

Ryo Atsumi, PhD, Satoshi Yoshiba, Dai Maruyama, MD PhD, Kensei Tobinai, MD PhD, Takashi Ishida, MD PhD, Kenji Ishitsuka, MD PhD, Yoshitaka Imaizumi, MD PhD, Shogo Takeuchi, MD, Kunihiro Tsukasaki, MD PhD, Nobuaki Adachi, PhD, Sumiaki Fujitani, MSc, Masaya Tachibana, PhD, Kazutaka Yoshihara, Hitoshi Ishizuka, PhD

Blood (2017) 130 (Supplement 1): 2544.

https://doi.org/10.1182/blood.V130.Suppl_1.2544.2544

Published: 2017

Journal Articles

Mogamulizumab Therapy for Adult T-Cell Leukemia-Lymphoma: A Retrospective Multicenter Study

Blood (2015) 126 (23): 2703.

https://doi.org/10.1182/blood.V126.23.2703.2703

Published: 2015

Journal Articles

Umbilical Cord Blood Transplantation with Non-TBI Regimens for Advanced Hematological Malignant Diseases

Nobuaki Nakano, MD, Yoshifusa Takatsuka, MD, Ayumu Kubota, MD, Masahito Tokunaga, MD, Mayumi Tokunaga, MD, PhD, Torahiko Makino, MD, PhD, Shogo Takeuchi, MD, Atae Utsunomiya, MD, PhD

Blood (2015) 126 (23): 5540.

https://doi.org/10.1182/blood.V126.23.5540.5540

Published: 2015

Journal Articles

Recent Significance of Allogeneic Hematopoietic Stem Cell Transplantation for Adult T Cell Leukemia/Lymphoma (ATL)

Masahito Tokunaga, MD, Nobuaki Nakano, MD, Ayumu Kubota, MD, Mayumi Tokunaga, MD, Takahiro Itoyama, MD, Torahiko Makino, MD, Shogo Takeuchi, MD, Yoshifusa Takatsuka, MD, Atae Utsunomiya, MD PhD

Blood (2014) 124 (21): 1241.

https://doi.org/10.1182/blood.V124.21.1241.1241

Published: 2014

Journal Articles

Extremely Higher Incidence of CMV-pp65 Antigenemia After Allogeneic Hematopoietic Stem Cell Transplantation in Adult T-Cell Leukemia/Lymphoma (ATL) Compared with Other Hematological Diseases

Nobuaki Nakano, M.D., Yoshifusa Takatsuka, M.D., Shogo Takeuchi, M.D., Masahito Tokunaga, M.D., Ayumu Kubota, M.D., Mayumi Tokunaga, M.D., Torahiko Makino, M.D., Atae Utsunomiya, MD, PhD

Blood (2012) 120 (21): 4477.

https://doi.org/10.1182/blood.V120.21.4477.4477

Published: 2012

Journal Articles

Early Deaths After Allogeneic Stem Cell Transplantation in Adult T Cell Leukemia/Lymphoma (ATLL) Patients - A Single Institute Retrospective Analysis

Shogo Takeuchi, MD, Nobuaki Nakano, MD, Ayumu Kubota, MD, Yoshifusa Takatsuka, MD, Mayumi Tokunaga, MD, Takahiro Itoyama, MD, Atae Utsunomiya, MD, PhD, Kentarou Yonekura, MD

Blood (2011) 118 (21): 4503.

https://doi.org/10.1182/blood.V118.21.4503.4503

Published: 2011

Journal Articles

Allogeneic Stem Cell Transplantation in 59 Patients with Adlut T-Cell Leukemia/Lymphoma-A Single center’s 13 Years Experience-

Nobuaki Nakano, MD, Yoshifusa Takatsuka, MD, Shogo Takeuchi, MD, Masahito Tokunaga, MD, Ayumu Kubota, MD, Mayumi Tokunaga, MD, Takahiro Itoyama, MD, Torahiko Makino, MD, Atae Utsunomiya, MD, PhD

Blood (2011) 118 (21): 4483.

https://doi.org/10.1182/blood.V118.21.4483.4483

Published: 2011

Journal Articles

GvATLL Effect in the Relapse and Progression Cases After Hematopoietic Stem Cell Transplantation (HSCT) for Adult T-Cell Leukemia/Lymphoma (ATLL).

Nobuaki Nakano, MD, Ayumu Kubota, MD, Mayumi Tokunaga, MD, Masahito Tokunaga, MD, Shogo Takeuchi, MD, Yosifusa Takatsuka, MD, Atae Utsunomiya, MD, PhD

Blood (2009) 114 (22): 4299.

https://doi.org/10.1182/blood.V114.22.4299.4299

Published: 2009

Journal Articles

Appropriate Patient Selection Before Allogenic Stem Cell Transplantation (allo-SCT) and Chronic GvHD After Allo-SCT Would Be Necessary for Better Outcome of Chemorefractory Non-Hodgkin's Lymphomas-A Single Institute Retrospective Study-.

Nobuaki Nakano, MD, Yosifusa Takatsuka, MD, Shogo Takeuchi, MD, Masahito Tokunaga, MD, Mayumi Tokunaga, MD, Ayumu Kubota, MD, Takahiro Itoyama, MD, Atae Utsunomiya, MD, PhD

Blood (2009) 114 (22): 4302.

https://doi.org/10.1182/blood.V114.22.4302.4302

Published: 2009

Journal Articles

Clinical Significance of Serum TARC/CCL17 in ATLL Patients: High TARC/CCL17 Level Is a Significant Unfavorable Prognostic Factor

Atsushi Inagaki, Takashi Ishida, Hiroki Yano, Fumiko Mori, Asahi Ito, Masaki Ri, Jianmin Ding, Shigeru Kusumoto, Hirokazu Komatsu, Shinsuke Iida, Kentaro Yonekura, Shogo Takeuchi, Yosifusa Takatsuka, Atae Utsunomiya, Ryuzo Ueda

Blood (2008) 112 (11): 2821.

https://doi.org/10.1182/blood.V112.11.2821.2821

Published: 2008

Journal Articles

Clinical Significance of Serum Th1-, Th2- and Regulatory T Cells-Associated Cytokines in Adult T-Cell Leukemia/Lymphoma: High Interleukin-5 and -10 Levels Are Significant Unfavorable Prognostic Factors.

Atsushi Inagaki, Takashi Ishida, Toshihiko Ishii, Hirokazu Komatsu, Shinsuke Iida, Kentaro Yonekura, Shogo Takeuchi, Yoshifusa Takatsuka, Atae Utsunomiya, Ryuzo Ueda

Blood (2005) 106 (11): 2828.

https://doi.org/10.1182/blood.V106.11.2828.2828

Published: 2005

NARROW

Cord Blood Transplantation with Non-TBI-RIC Regimen Using Fludarabine and Melphalan for Adult T-Cell Leukemia / Lymphoma

DS-3201, a Potent EZH1/2 Dual Inhibitor, Demonstrates Antitumor Activity Against Non-Hodgkin Lymphoma (NHL) Regardless of EZH2 Mutation

First-in-Human Study of the EZH1/2 Dual Inhibitor DS-3201b in Patients with Relapsed or Refractory Non-Hodgkin Lymphomas — Preliminary Results

Population Pharmacokinetic and Exposure-Response Modeling for the EZH1/2 Dual Inhibitor DS-3201b in Patients with Non-Hodgkin Lymphomas

Mogamulizumab Therapy for Adult T-Cell Leukemia-Lymphoma: A Retrospective Multicenter Study

Umbilical Cord Blood Transplantation with Non-TBI Regimens for Advanced Hematological Malignant Diseases

Recent Significance of Allogeneic Hematopoietic Stem Cell Transplantation for Adult T Cell Leukemia/Lymphoma (ATL)

Extremely Higher Incidence of CMV-pp65 Antigenemia After Allogeneic Hematopoietic Stem Cell Transplantation in Adult T-Cell Leukemia/Lymphoma (ATL) Compared with Other Hematological Diseases

Early Deaths After Allogeneic Stem Cell Transplantation in Adult T Cell Leukemia/Lymphoma (ATLL) Patients - A Single Institute Retrospective Analysis

Allogeneic Stem Cell Transplantation in 59 Patients with Adlut T-Cell Leukemia/Lymphoma-A Single center’s 13 Years Experience-

GvATLL Effect in the Relapse and Progression Cases After Hematopoietic Stem Cell Transplantation (HSCT) for Adult T-Cell Leukemia/Lymphoma (ATLL).

Appropriate Patient Selection Before Allogenic Stem Cell Transplantation (allo-SCT) and Chronic GvHD After Allo-SCT Would Be Necessary for Better Outcome of Chemorefractory Non-Hodgkin's Lymphomas-A Single Institute Retrospective Study-.

Clinical Significance of Serum TARC/CCL17 in ATLL Patients: High TARC/CCL17 Level Is a Significant Unfavorable Prognostic Factor

Clinical Significance of Serum Th1-, Th2- and Regulatory T Cells-Associated Cytokines in Adult T-Cell Leukemia/Lymphoma: High Interleukin-5 and -10 Levels Are Significant Unfavorable Prognostic Factors.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only